Metabolic traits of cancer stem cells

Area of Science:

• Oncology
• Cancer Biology
• Cellular Metabolism

Background:

• Cancer stem cells (CSCs) are implicated in tumor recurrence and resistance to conventional therapies.
• The metabolic characteristics of CSCs remain largely unexplored, representing a critical knowledge gap in cancer research.
• Existing research suggests CSCs exhibit distinct metabolic phenotypes, though variations exist based on cancer type and experimental models.

Purpose of the Study:

• To review and synthesize current knowledge on the metabolic phenotype of cancer stem cells.
• To explore the role of specific metabolic pathways, including glycolysis, oxidative metabolism, and amino/fatty acid metabolism, in CSCs.
• To identify how metabolic alterations regulate cancer stemness and contribute to therapeutic resistance.

Main Methods:

• Comprehensive literature review of studies investigating cancer stem cell metabolism.
• Analysis of metabolic pathways, including glycolysis, oxidative phosphorylation, glutaminolysis, and fatty acid metabolism.
• Examination of altered metabolic enzymes and metabolite levels associated with cancer stemness.

Main Results:

• CSCs display a distinct metabolic profile that differs from bulk tumor cells.
• Key metabolic pathways such as glycolysis, glutaminolysis, and fatty acid metabolism are significantly altered in CSCs.
• Specific metabolic enzymes and metabolite concentrations are identified as regulators of cancer stem cell properties.

Conclusions:

• Metabolic reprogramming is a crucial factor supporting the survival and resistance of cancer stem cells.
• Targeting CSC-specific metabolic vulnerabilities presents a promising strategy for developing novel cancer therapies.
• Interventions aimed at CSC metabolism could lead to more effective treatments, potentially eradicating tumors and preventing relapse.